BioSpace News Archive

Calliditas Therapeutics AB announced the appointment of three industry veterans: Warren Brooks, PhD, as Vice President of US Medical Affairs, Teona Johnson as Head of US Marketing and David Ferraro as Head of US Sales.

Medivir AB announces that the company will present at the virtual meeting H.C. Wainwright Global Life Sciences Conference, March 9-10.

Rokote Laboratories Finland Ltd., a newly-founded academic spin-out based in Finland is working to develop and introduce to the markets a nasal spray vaccine against COVID.

Leading Acne Brand Aims to Educate Consumers and Share the Experience of Consistently Clear Skin Through Giveaway of 5,000 Differin Gel Products

MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market and the JASDAQ Market of the Tokyo Stock Exchange, announced that MediciNova will present at the Inaugural Emerging Growth Virtual Conference, presented by M Vest LLC and Maxim Group LLC.

The board of directors of Medtronic plc (NYSE: MDT) on Friday, March 5, 2021 , approved the fiscal year 2021 fourth quarter cash dividend of $0.58 per ordinary share, representing a 7.4 percent increase over the prior year. This quarterly declaration is consistent with the dividend announcement made by the company in May 2020.

BWXT Medical Ltd. and Global Medical Solutions, Ltd. have entered into a joint venture to manufacture and distribute radioisotopes and radiopharmaceuticals in the Asia-Pacific.

NovaBay Pharmaceuticals to Participate in Virtual 33 rd Annual Roth Conference

Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with cancer, today announced management will participate in three upcoming virtual investor conferences: H.C. Wainwright Global Life Sciences Conference: March 9-10, 2021 33rd Annual ROTH Conference: March 15-17, 2021 Maxim Emerging Growth Conference: March 17-18, 2021

Vivos Therapeutics, Inc. (“the Company”) (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative treatments for patients suffering from sleep-disordered breathing, including mild-to-moderate obstructive sleep apnea (OSA), today announced the opening of the first Pneusomnia clinic,